|
Volumn 59, Issue 2, 2002, Pages 150-178
|
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
a a a a a a a a a a a a a a
a
NONE
|
Author keywords
American Society of Health System Pharmacists; Analgesics and antipyretics; Anxiolytics, sedatives and hypnotics; Critical illness; Dosage schedules; Guidelines
|
Indexed keywords
ALFENTANIL;
ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT;
ANALGESIC AGENT;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE;
CLONIDINE;
CODEINE;
DEXMEDETOMIDINE;
DIAZEPAM;
FENTANYL;
HALOPERIDOL;
HYDROMORPHONE;
IBUPROFEN;
KETOROLAC;
LAXATIVE;
LORAZEPAM;
MIDAZOLAM;
MONOAMINE OXIDASE INHIBITOR;
MORPHINE;
NEUROLEPTIC AGENT;
NONSTEROID ANTIINFLAMMATORY AGENT;
OPIATE;
PARACETAMOL;
PETHIDINE;
PROPOFOL;
REMIFENTANIL;
SEDATIVE AGENT;
SEROTONIN UPTAKE INHIBITOR;
SUFENTANIL;
UNINDEXED DRUG;
ADULT;
ANALGESIA;
CLINICAL TRIAL;
CONSTIPATION;
CRITICAL ILLNESS;
DELIRIUM;
DOSE CALCULATION;
DRUG CHOICE;
DRUG EFFICACY;
DRUG INDUCED DISEASE;
DRUG SAFETY;
GASTROINTESTINAL HEMORRHAGE;
HUMAN;
HYPOTENSION;
MAINTENANCE THERAPY;
MEDICAL SOCIETY;
MUSCLE RIGIDITY;
PAIN ASSESSMENT;
PATIENT MONITORING;
PRACTICE GUIDELINE;
PRIORITY JOURNAL;
RESPIRATION DEPRESSION;
REVIEW;
SEDATION;
SLEEP;
|
EID: 0037081983
PISSN: 10792082
EISSN: None
Source Type: Journal
DOI: 10.1093/ajhp/59.2.150 Document Type: Review |
Times cited : (55)
|
References (235)
|